… clinical results for patients with neovascular age-related macular degeneration (nAMD) who
… Long-term analyses of anti-VEGF efficacy for nAMD are emerging. Both the extension trials …

… for neovascular age-related macular degeneration (nAMD). … , that are seen as suboptimal
responders or treatment failures … on SD-OCT with consistent long term aflibercept therapy. …

… for their retrospective description of the clinical outcomes of 67 patients with neovascular
age-related macular degeneration (nAMD) using a variation of treat and extend management. …

… There are 3 main treatment strategies to control and improve … and vision returned to the best
treated VA at 0.55 and … new and important elements of long-term treatment success. Finally, …

… who had long-term therapy and we … neovascular age-related macular degeneration. Vision
was examined after the 50th injection as a point of constancy owing to variability in treatment …

… This has also been described in multiple long-term extension studies of clinical … long-term
results of neovascular age-related macular degeneration (nAMD) requiring consistent therapy …

… We also examined the long-term results managing patients … in the short- and long-term,
patients are able to significantly … regimens more consistently and proactively treat disease, …

… ) drugs have been used for the treatment of this disease for more than a decade, changing
… Currently, there are different series published on the long-term results of AMD after treatment …

… treatment strategy in patients with neovascular age-related … disease that requires continuous
and long-term follow-up. … , Adrean et al 7 reported good visual recovery after treatment …

… with neovascular age-related macular degeneration (nAMD) … letters were lost using the best
corrected visual acuity score … outcomes over the long term, multiple treatments were required …